medigraphic.com
Colegio de Medicos y Cirujanos República de Costa Rica

2014, Number 612

<< Back Next >>

Rev Med Cos Cen 2014; 71 (612)

Cáncer Colorrectal:
Un enfoque actualizado del tamizaje y epidemiología

Granados MÉ

Language: Spanish
References: 29
Page: 763-770
PDF size: 491.02 Kb.


ABSTRACT

Colorectal cancer is one of the most feared diseases in our society. It is that common, that is essential to be updated on this pathology. At the same time it´s a dangerous disease that must be taken into account in our daily practice, it can be misdiagnosed because of the subclinical presentation that carries on many of the affected patients. In this setting, we as medical doctors must be accurate in identifying the risk factors, diagnosing the disease, and referring the patient to the surgeon specialist when optimal treatment is necessary. This article presents a simple, but updated recompilation of the epidemiology, risk factors, clinical presentation, and principal screening recommendations of this important disease, with an evidence based medicine point of view that will improve the reader´s medical decisions in the future.


REFERENCES

  1. A., Franco; A. K., Sikalidis; J. A., Solís Herruzo. Colorectal cancer: influence of diet and lifestyle factors / Cáncer de colon: influencia de la dieta y el estilo de vida. Rev. esp. enferm. dig.; 97(6); 432-448; 2005- 06. SciELO Espanha | Idioma: Inglês

  2. Anderson JC, Shaw RD. Update on colon cancer screening: recent advances and observations in colorectal cancer screening. Curr Gastroenterol Rep. 2014, Sep;16(9):403. doi: 10.1007/ s11894-014-0403-3. PubMed PMID: 25108645.

  3. Armelao F, de Pretis G. Familial colorectal cancer: A review. World J Gastroenterol. 2014 Jul 28;20(28):9292-9298. Review. PubMed PMID:25071323; PubMed Central PMCID: PMC4110560.

  4. Baber J, Anusionwu C, Nanavaty N, Agrawal S. Anatomical distribution of colorectal cancer in a veterans affairs medical center. South Med J. 2014 Jul;107(7):443-7. doi:10.14423/ SMJ.0000000000000135. PubMed PMID: 25010587.

  5. Bu WJ, Song L, Zhao DY, Guo B, Liu J. Insulin therapy and the risk of colorectal cancer in patients with type 2 diabetes: a meta-analysis of observational studies. Br J Clin Pharmacol. 2014 Aug;78(2):301- 9. doi:10.1111/bcp.12350. PubMed PMID: 25099257.

  6. Carroll MR, Seaman HE, Halloran SP. Tests and investigations for colorectal cancer screening. Clin Biochem. 2014 Jul;47(10-11):921-39. doi:10.1016/j. clinbiochem.2014.04.019. Epub 2014 Apr 24. PubMed PMID:24769265.

  7. Clifford GM, Polesel J, Rickenbach M, et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 2005; 97:425.

  8. Giardiello FM, Allen JI, Axilbund JE, Boland CR, Burke CA. Guidelines on Genetic Evaluation and Management of Lynch Syndrome: A Consensus Statement by the US Multi- Society Task Force on Colorectal Cancer. Gastroenterology. 2014 Aug;147(2):502-26. doi:10.1053/j. gastro.2014.04.001. PubMed PMID: 25043945.

  9. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011; 61:69.

  10. Kim ER, Chang DK. Colorectal cancer in inflammatory bowel disease: The risk, pathogenesis, prevention and diagnosis. World J Gastroenterol. 2014 Aug7;20(29):9872-9881. Review. PubMed PMID: 25110418.

  11. Lagergren J, Ye W, Ekbom A. Intestinal cancer after cholecystectomy: is bile involved in carcinogenesis? Gastroenterology 2001; 121:542.

  12. Lois K, Bukowczan J, Perros P, Jones S, Gunn M, James RA. The role of colonoscopic screening in acromegaly revisited: review of current literature and practice guidelines. Pituitary.2014 Jul 23.PubMed PMID:25052731.

  13. Ma J, Ledbetter N, Glenn L. Testing women with endometrial cancer for lynch syndrome: should we test all? J Adv Pract Oncol. 2013 Sep;4(5):322- 30.Review. PubMed PMID: 25032011; PubMed Central PMCID: PMC4093445.

  14. Mamazza J, Gordon PH. The changing distribution of large intestinal cancer. Dis Colon Rectum 1982; 25:558.

  15. Park JM, Choi MG, Kim SW, et al. Increased incidence of colorectal malignancies in renal transplant recipients: a case control study. Am J Transplant 2010; 10:2043.

  16. Phelan CM, Iqbal J, Lynch HT, Lubinski J, Gronwald J, Moller P, Ghadirian P; Hereditary Breast Cancer Study Group. Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study. Br J Cancer. 2014 Jan 21;110(2):530-4. doi: 10.1038/ bjc.2013.741. Epub 2013 Nov 28. PubMed PMID:24292448; PubMed Central PMCID: PMC3899769.

  17. Rex DK, Johnson DA, Anderson JC, et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol 2009; 104:739.

  18. Saidi HS, Karuri D, Nyaim EO. Correlation of clinical data, anatomical site and disease stage in colorectal cancer. East Afr Med J. 2008, Jun;85(6):259-62. PubMed PMID: 18817021.

  19. Schub R, Steinheber FU. Rightward shift of colon cancer. A feature of the aging gut. J Clin Gastroenterol 1986; 8:630.

  20. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014; 64:9.

  21. Singh H, Nugent Z, Demers A, et al. Risk of colorectal cancer after diagnosis of endometrial cancer: a population-based study. J Clin Oncol 2013; 31:2010.

  22. Speights VO, Johnson MW, Stoltenberg PH, Rappaport ES, Helbert B, Riggs M. Colorectal cancer: current trends in initial clinical manifestations.South Med J. 1991 May;84(5):575-8. PubMed PMID: 2035076.

  23. Sponsor executive summary. Cologuard sDNA-Based Colorectal Cancer Screening Test. Exact Sciences Corporation. March 27, 2014. Extraído de: http://www.fda. gov/downloads/advisorycommittees/ committeesmeetingmaterials/ m edicaldevices/ medicaldevicesadvisorycommittee/ molecularandclinicalgeneticspanel/ ucm390227.pdf.[Consulta: Jueves, 14 de Agosto de 2014]

  24. Steffen A, MacInnis RJ, Joshy G, Giles GG, Banks E, Roder D. Development and validation of a risk score predicting risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2014 Aug 3. pii: cebp.0206.2014. PubMed PMID: 25087576.

  25. Szablewski L. Diabetes mellitus influences on cancer risk. Diabetes Metab Res Rev. 2014 Jul 4. doi: 10.1002/dmrr.2573. [Epub ahead of print] PubMed PMID:25044584.

  26. Tatiana, Barrantes Solís. Principales Causas de Cáncer Atendidas en un Centro Hospitalario: Costa Rica 2003-2007 / Main Causes of Cancer in a Hospital Center: Costa Rica 2003- 2007. Rev. costarric. salud pública; 18(1); 37-42; 2009-07. SciELO Costa Rica | Idioma: Espanhol

  27. Thörn M, Bergström R, Kressner U, et al. Trends in colorectal cancer incidence in Sweden 1959-93 by gender, localization, time period, and birth cohort. Cancer Causes Control 1998; 9:145.

  28. Weinberg DS, Schoen RE. Screening for colorectal cancer. Ann Intern Med. 2014, May 6;160(9). doi: 10.7326/0003-4819-160-9- 201405060-01005. Review. PubMed PMID:24798544.

  29. Zhu JZ, Wang YM, Zhou QY, Zhu KF, Yu CH, Li YM. Systematic review with meta-analysis: alcohol consumption and the risk of colorectal adenoma. Aliment. Pharmacol Ther. 2014 Aug;40(4):325-37. doi: 10.1111/apt.12841. Epub 2014, Jun 18. PubMed PMID: 24943329




2020     |     www.medigraphic.com